A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

NCT00601107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Chronic Plaque Psoriasis

Interventions

DRUG: Doxercalciferol
DRUG: Placebo

Sponsor

Genzyme, a Sanofi Company